Some studies reported no NAFLD improvement [37], others reported an improvement in the levels of alanine aminotransferase, aspartate aminotransferase, glucose, triglycerides, steatosis, and body mass index but not liver fibrosis score [38,39]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.